| Primary |
| Cataract Operation |
16.6% |
| Postoperative Care |
16.0% |
| Prophylaxis |
12.8% |
| Keratitis Fungal |
5.3% |
| Antibiotic Prophylaxis |
4.8% |
| Conjunctivitis Infective |
4.8% |
| Endophthalmitis |
4.8% |
| Ulcerative Keratitis |
4.8% |
| Conjunctivitis Bacterial |
4.3% |
| Keratitis |
4.3% |
| Preoperative Care |
4.3% |
| Conjunctivitis |
3.7% |
| Eye Discharge |
2.7% |
| Antibiotic Therapy |
1.6% |
| Corneal Infiltrates |
1.6% |
| Eye Infection |
1.6% |
| Eye Inflammation |
1.6% |
| Glaucoma |
1.6% |
| Infection Prophylaxis |
1.6% |
| Depression |
1.1% |
|
| Endophthalmitis |
11.5% |
| Off Label Use |
11.5% |
| Visual Acuity Reduced |
11.5% |
| Vision Blurred |
7.3% |
| Eye Pain |
6.3% |
| Drug Ineffective |
5.2% |
| Therapy Non-responder |
5.2% |
| Ulcerative Keratitis |
5.2% |
| Urticaria |
5.2% |
| Keratitis Fungal |
4.2% |
| Vitritis |
4.2% |
| Epistaxis |
3.1% |
| Hypersensitivity |
3.1% |
| Photophobia |
3.1% |
| Poor Quality Drug Administered |
3.1% |
| Anaphylactic Shock |
2.1% |
| Complications Of Transplant Surgery |
2.1% |
| Corneal Abrasion |
2.1% |
| Corneal Erosion |
2.1% |
| Drug Hypersensitivity |
2.1% |
|
| Secondary |
| Cataract Operation |
30.8% |
| Postoperative Care |
24.4% |
| Intraocular Lens Implant |
16.0% |
| Preoperative Care |
12.7% |
| Prophylaxis |
5.3% |
| Mydriasis |
2.8% |
| Keratitis Bacterial |
1.5% |
| Conjunctivitis Allergic |
0.8% |
| Corneal Abrasion |
0.8% |
| Dry Eye |
0.8% |
| Pharyngitis |
0.8% |
| Cataract Operation Complication |
0.6% |
| Conjunctivitis |
0.4% |
| Eye Disorder |
0.4% |
| Eye Irrigation |
0.4% |
| Photorefractive Keratectomy |
0.4% |
| Product Used For Unknown Indication |
0.4% |
| Eye Operation |
0.3% |
| High Cholesterol |
0.3% |
| Hypertension |
0.3% |
|
| Toxic Anterior Segment Syndrome |
56.7% |
| Medication Error |
6.7% |
| Off Label Use |
6.7% |
| Visual Acuity Reduced |
4.7% |
| Post Procedural Complication |
3.3% |
| Hypersensitivity |
2.0% |
| Intraocular Pressure Increased |
2.0% |
| Visual Impairment |
2.0% |
| Drug Ineffective |
1.3% |
| Endophthalmitis |
1.3% |
| Extraocular Muscle Paresis |
1.3% |
| Eye Irritation |
1.3% |
| Eye Pain |
1.3% |
| Hypopyon |
1.3% |
| Nausea |
1.3% |
| Product Quality Issue |
1.3% |
| Skin Exfoliation |
1.3% |
| Tendon Pain |
1.3% |
| Ulcerative Keratitis |
1.3% |
| Weight Increased |
1.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
31.3% |
| Product Used For Unknown Indication |
28.9% |
| Rheumatoid Arthritis |
10.1% |
| Macular Degeneration |
4.1% |
| Age-related Macular Degeneration |
3.8% |
| Tonsil Cancer |
2.7% |
| Prophylaxis |
2.3% |
| Cataract |
2.2% |
| Cataract Operation |
2.2% |
| Postoperative Care |
1.9% |
| Pain |
1.5% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Contraception |
1.1% |
| Premedication |
1.1% |
| Osteoporosis |
1.1% |
| Atrial Fibrillation |
1.0% |
| Acne |
0.9% |
| Depression |
0.9% |
| Insomnia |
0.9% |
| Eye Disorder |
0.8% |
|
| Visual Acuity Reduced |
15.2% |
| Weight Decreased |
11.2% |
| Endophthalmitis |
9.1% |
| Retinal Haemorrhage |
8.6% |
| Progressive Multifocal Leukoencephalopathy |
6.6% |
| Vision Blurred |
5.1% |
| Anterior Chamber Inflammation |
4.6% |
| Vomiting |
4.6% |
| Toxic Anterior Segment Syndrome |
3.6% |
| Vitritis |
3.6% |
| Cerebral Infarction |
3.0% |
| Death |
3.0% |
| Ulcerative Keratitis |
3.0% |
| Uveitis |
3.0% |
| Vitreous Haemorrhage |
3.0% |
| Cataract |
2.5% |
| Chest Pain |
2.5% |
| Intraocular Pressure Increased |
2.5% |
| Retinal Tear |
2.5% |
| Somnambulism |
2.5% |
|
| Interacting |
| Corneal Lesion |
33.3% |
| Eye Infection |
33.3% |
| Tachycardia |
33.3% |
|
|
